Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Surgical Outcomes After Pancreatic Resection of Screening-Detected Lesions in Individuals at High Risk for Developing Pancreatic Cancer.

Canto MI, Kerdsirichairat T, Yeo CJ, Hruban RH, Shin EJ, Almario JA, Blackford A, Ford M, Klein AP, Javed AA, Lennon AM, Zaheer A, Kamel IR, Fishman EK, Burkhart R, He J, Makary M, Weiss MJ, Schulick RD, Goggins MG, Wolfgang CL.

J Gastrointest Surg. 2019 Jun 13. doi: 10.1007/s11605-019-04230-z. [Epub ahead of print]

PMID:
31197699
2.

Risk of Neoplastic Progression in Individuals at High Risk for Pancreatic Cancer Undergoing Long-term Surveillance.

Canto MI, Almario JA, Schulick RD, Yeo CJ, Klein A, Blackford A, Shin EJ, Sanyal A, Yenokyan G, Lennon AM, Kamel IR, Fishman EK, Wolfgang C, Weiss M, Hruban RH, Goggins M.

Gastroenterology. 2018 Sep;155(3):740-751.e2. doi: 10.1053/j.gastro.2018.05.035. Epub 2018 May 24.

PMID:
29803839
3.

A multicentre comparative prospective blinded analysis of EUS and MRI for screening of pancreatic cancer in high-risk individuals.

Harinck F, Konings IC, Kluijt I, Poley JW, van Hooft JE, van Dullemen HM, Nio CY, Krak NC, Hermans JJ, Aalfs CM, Wagner A, Sijmons RH, Biermann K, van Eijck CH, Gouma DJ, Dijkgraaf MG, Fockens P, Bruno MJ; Dutch research group on pancreatic cancer surveillance in high-risk individuals.

Gut. 2016 Sep;65(9):1505-13. doi: 10.1136/gutjnl-2014-308008. Epub 2015 May 18.

PMID:
25986944
4.

Laparoscopic versus open distal pancreatectomy for pancreatic cancer.

Riviere D, Gurusamy KS, Kooby DA, Vollmer CM, Besselink MG, Davidson BR, van Laarhoven CJ.

Cochrane Database Syst Rev. 2016 Apr 4;4:CD011391. doi: 10.1002/14651858.CD011391.pub2. Review.

PMID:
27043078
5.

Surgical experience with pancreatic and periampullary cancer.

Herter FP, Cooperman AM, Ahlborn TN, Antinori C.

Ann Surg. 1982 Mar;195(3):274-81.

6.

Second primary pancreatic ductal carcinoma in the remnant pancreas after pancreatectomy for pancreatic ductal carcinoma: High cumulative incidence rates at 5 years after pancreatectomy.

Ishida J, Toyama H, Matsumoto I, Asari S, Goto T, Terai S, Nanno Y, Yamashita A, Mizumoto T, Ueda Y, Kido M, Ajiki T, Fukumoto T, Ku Y.

Pancreatology. 2016 Jul-Aug;16(4):615-20. doi: 10.1016/j.pan.2016.05.003. Epub 2016 May 14.

PMID:
27237099
7.

Impact of diabetes mellitus on perioperative outcomes after resection for pancreatic adenocarcinoma.

Chu CK, Mazo AE, Sarmiento JM, Staley CA, Adsay NV, Umpierrez GE, Kooby DA.

J Am Coll Surg. 2010 Apr;210(4):463-73. doi: 10.1016/j.jamcollsurg.2009.12.029.

PMID:
20347739
8.

Benefit of Surveillance for Pancreatic Cancer in High-Risk Individuals: Outcome of Long-Term Prospective Follow-Up Studies From Three European Expert Centers.

Vasen H, Ibrahim I, Ponce CG, Slater EP, Matthäi E, Carrato A, Earl J, Robbers K, van Mil AM, Potjer T, Bonsing BA, de Vos Tot Nederveen Cappel WH, Bergman W, Wasser M, Morreau H, Klöppel G, Schicker C, Steinkamp M, Figiel J, Esposito I, Mocci E, Vazquez-Sequeiros E, Sanjuanbenito A, Muñoz-Beltran M, Montans J, Langer P, Fendrich V, Bartsch DK.

J Clin Oncol. 2016 Jun 10;34(17):2010-9. doi: 10.1200/JCO.2015.64.0730. Epub 2016 Apr 25.

PMID:
27114589
9.

Intraoperative irrigation cytology of the remnant pancreas to detect remnant distinct pancreatic ductal adenocarcinoma in patients with intraductal papillary mucinous neoplasm undergoing partial pancreatectomy.

Mori Y, Ohtsuka T, Tamura K, Ideno N, Aso T, Kono H, Nagayoshi Y, Ueda J, Takahata S, Aishima S, Ookubo F, Oda Y, Tanaka M.

Surgery. 2014 Jan;155(1):67-73. doi: 10.1016/j.surg.2013.06.059. Epub 2013 Oct 29.

PMID:
24183345
10.

Curative resection of pancreatic ductal adenocarcinoma developing in the remnant pancreas 13 years after distal pancreatectomy for intraductal papillary mucinous neoplasms: A case report.

Einama T, Kamachi H, Sakata T, Shibata K, Wakizaka K, Sugiyama K, Shibuya K, Shimada S, Wakayama K, Orimo T, Yokoo H, Kamiyama T, Mitsuhashi T, Taketomi A.

Mol Clin Oncol. 2018 Mar;8(3):417-420. doi: 10.3892/mco.2018.1556. Epub 2018 Jan 16.

11.

Asymptomatic Pancreatic Cancer: Does Incidental Detection Impact Long-Term Outcomes?

Takeda Y, Saiura A, Takahashi Y, Inoue Y, Ishizawa T, Mise Y, Matsumura M, Ichida H, Matsuki R, Tanaka M, Ito H.

J Gastrointest Surg. 2017 Aug;21(8):1287-1295. doi: 10.1007/s11605-017-3421-2. Epub 2017 Apr 10.

PMID:
28397027
12.

Predictive Factors for the Metachronous Development of High-risk Lesions in the Remnant Pancreas After Partial Pancreatectomy for Intraductal Papillary Mucinous Neoplasm.

Miyasaka Y, Ohtsuka T, Tamura K, Mori Y, Shindo K, Yamada D, Takahata S, Ishigami K, Ito T, Tokunaga S, Oda Y, Mizumoto K, Nakamura M, Tanaka M.

Ann Surg. 2016 Jun;263(6):1180-7. doi: 10.1097/SLA.0000000000001368.

PMID:
26334637
13.

Laparoscopic distal pancreatectomy for pancreatic cancer is safe and effective.

Bauman MD, Becerra DG, Kilbane EM, Zyromski NJ, Schmidt CM, Pitt HA, Nakeeb A, House MG, Ceppa EP.

Surg Endosc. 2018 Jan;32(1):53-61. doi: 10.1007/s00464-017-5633-7. Epub 2017 Jun 22.

PMID:
28643065
14.

Follow-up study after resection of intraductal papillary mucinous neoplasm of the pancreas; special references to the multifocal lesions and development of ductal carcinoma in the remnant pancreas.

Ohtsuka T, Kono H, Tanabe R, Nagayoshi Y, Mori Y, Sadakari Y, Takahata S, Oda Y, Aishima S, Igarashi H, Ito T, Ishigami K, Nakamura M, Mizumoto K, Tanaka M.

Am J Surg. 2012 Jul;204(1):44-8. doi: 10.1016/j.amjsurg.2011.04.007. Epub 2011 Oct 13.

PMID:
21996346
15.

The prognostic influence of intrapancreatic tumor location on survival after resection of pancreatic ductal adenocarcinoma.

Ruess DA, Makowiec F, Chikhladze S, Sick O, Riediger H, Hopt UT, Wittel UA.

BMC Surg. 2015 Nov 28;15:123. doi: 10.1186/s12893-015-0110-5.

16.

Proposed preoperative risk factors for early recurrence in patients with resectable pancreatic ductal adenocarcinoma after surgical resection: A multi-center retrospective study.

Matsumoto I, Murakami Y, Shinzeki M, Asari S, Goto T, Tani M, Motoi F, Uemura K, Sho M, Satoi S, Honda G, Yamaue H, Unno M, Akahori T, Kwon AH, Kurata M, Ajiki T, Fukumoto T, Ku Y.

Pancreatology. 2015 Nov-Dec;15(6):674-80. doi: 10.1016/j.pan.2015.09.008. Epub 2015 Oct 3.

PMID:
26467797
17.

Is laparoscopic resection adequate in patients with neuroendocrine pancreatic tumors?

Fernández-Cruz L, Blanco L, Cosa R, Rendón H.

World J Surg. 2008 May;32(5):904-17. doi: 10.1007/s00268-008-9467-2.

PMID:
18264824
18.

Is distal pancreatectomy with en-bloc celiac axis resection effective for patients with locally advanced pancreatic ductal adenocarcinoma? -Multicenter surgical group study.

Yamamoto T, Satoi S, Kawai M, Motoi F, Sho M, Uemura KI, Matsumoto I, Honda G, Okada KI, Akahori T, Toyama H, Kurata M, Yanagimoto H, Yamaue H, Unno M, Kon M, Murakami Y.

Pancreatology. 2018 Jan;18(1):106-113. doi: 10.1016/j.pan.2017.11.005. Epub 2017 Nov 14.

PMID:
29153701
19.

Laparoscopic Distal Pancreatectomy for Cancer Provides Oncologic Outcomes and Overall Survival Identical to Open Distal Pancreatectomy.

Kantor O, Bryan DS, Talamonti MS, Lutfi W, Sharpe S, Winchester DJ, Prinz RA, Baker MS.

J Gastrointest Surg. 2017 Oct;21(10):1620-1625. doi: 10.1007/s11605-017-3506-y. Epub 2017 Aug 1.

PMID:
28766272
20.

Laparoscopic radical 'no-touch' left pancreatosplenectomy for pancreatic ductal adenocarcinoma: technique and results.

Abu Hilal M, Richardson JR, de Rooij T, Dimovska E, Al-Saati H, Besselink MG.

Surg Endosc. 2016 Sep;30(9):3830-8. doi: 10.1007/s00464-015-4685-9. Epub 2015 Dec 16.

Supplemental Content

Support Center